Agosto-Octubre 2000 5
ISSN 1317-987X
 
Buscar




Artículos
 



Biología celular
El receptor del factor de crecimiento epidérmico

Bibliografía

  • Alroy I; Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. Federation European Biochemical Societies Letters, 1997 Jun, 410 (1): 83-6.
  • Anderson D; Koch CA; Grey L; Ellis C; Moran MF; Pawson T. Binding of SH2 domains of phospholipase Cg1, GAP, and Src to activated growth factor receptors. Science, 1990 Nov, 250 (4983): 979-82.
  • Auricchio A; di Domenico M; Castoria G; Bilancio A; Migliaccio A. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. Federation European Biochemical Societies Letters, 1994 Oct, 353 (1): 16-20.
  • Barbier AJ; Poppleton HM; Yigzaw Y; Mullenix JB; Wiepz GJ; Bertics PJ; Patel TB. Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. Journal of Biological Chemistry, 1999 May, 274 (20): 14067-73.
  • Bell GI; Fong NM; Siempien MM; Wormsted MA; Caput D; Ku LL; Urdea MS; Rall LB; Sanchez-Pescador R. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Research, 1986 Nov, 14 (21): 8427-46.
  • Benaim G; Cervino V; Villalobo A. Comparative phosphorylation of calmodulin from trypanosomatids and bovine brain by calmodulin-binding protein kinases. Comparative Biochemistry and Physiology. Part C-Pharmacology Toxicology and Endocrinology, 1998 Jul, 120 (1): 57-65.
  • Benguría A; Villalobo A. Calmodulin and the epidermal growth factor receptor: A reciprocal regulation? Bio-Reguladores, 1993 Dec, 2 (2): 74-85.
  • Benguría A; Hernández-Perera O; Martínez-Pastor MT; Sacks DB; Villalobo A. Phosphorylation of calmodulin by the epidermal-growth-factor-receptor tyrosine kinase. European Journal of Biochemistry, 1994 Sep, 224 (3): 909-16.
  • Benguría A; Martín-Nieto J; Benaim G; Villalobo A. Regulatory interaction between calmodulin and the epidermal growth factor receptor. Annals of the New York Academy of Sciences, 1995 Sep, 766: 472-6.
  • Biscardi JS; Maa MC; Tice DA; Cox ME; Leu TH; Parsons SJ. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor funtion. Journal of Biological Chemistry, 1999 Mar, 19 (12): 8335-43.
  • Boonstra J; Rijken P; Humbel B; Cremers F; Verkleij A; Van Bergen en Henegouwen P. The epidermal growth factor. Cell Biology International, 1995 May, 19 (5): 413-30.
  • Borst P; Fairlamb AH. Surface receptors and transporters of Trypanosoma brucei. Annual Review of Microbiology, 1998, 52: 745-78.
  • Cadena DL; Gill GN. Receptor tyrosine kinases. Federation American Societies of Experimental Biology Journal, 1992 Mar, 6 (6): 2332-7.
  • Campos-González R; Glenney JR. Tyrosine phosphorylation of mitogen-activated protein kinase in cells with tyrosine kinase-negative epidermal growth factor receptors. Journal of Biological Chemistry, 1992 Jul, 267 (21): 14535-8.
  • Cardone MH; Roy N; Stennicke HR; Salvesen GS; Franke TF; Stanbridge E; Frisch S; Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science, 1998 Nov, 282 (5392): 1318-21.
  • Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annual Review of Biochemistry, 1987, 56: 881-914.
  • Carpenter G; Cohen S. Epidermal growth factor. Annual Review of Biochemistry, 1979, 48: 193-216.
  • Carpenter G; Cohen S. Epidermal growth factor. Journal of Biological Chemistry, 1990 May, 265 (14): 7709-12.
  • Carpenter G; Zendegui JG. Epidermal growth factor, its receptor, and related proteins. Experimental Cell Research, 1986 May, 164 (1): 1-10.
  • Carraway KL; Burden SJ. Neuregulins and their receptors. Current Opinion in Neurobiology, 1995 Oct, 5 (5): 606-12.
  • Carraway KL; Weber JL; Unger MJ; Ledesma J; Yu N; Gassmann M; Lai C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature, 1997 May, 387 (6632): 512-6.
  • Casci T; Freeman M. Control of EGF receptor signalling: lessons from fruitflies. Cancer Metastasis Review, 1999, 18 (2): 181-201.
  • Cobb MH. MAP kinase pathways. Progress in Biophysics and Molecular Biology, 1999, 71 (3-4): 479-500.
  • Corti C; LeClerc L'Hostis E; Quadroni M; Schmid H; Durussel Y; Cox J; Hatt PD; James P; Carafoli E. 1999. Tyrosine phosphorylation modulates the interaction of calmodulin with its target proteins. European Journal of Biochemistry, 1999 Jun, 262 (3): 790-802.
  • Coso OA; Chiariello M; Yu JC; Teramoto H; Crespo P; Xu N; Miki T; Gutkind JS. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 1995 Jun, 81 (7): 1137-46
  • Countaway JL; McQuilkin P; Girones N; Davis RJ. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation. Journal of Biological Chemistry, 1990 Feb, 265 (6): 3407-16.
  • Countaway JL; Nairn AC; Davis RJ. Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase. Journal of Biological Chemistry, 1992 Jan, 267 (2): 1129-40.
  • Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature, 1997 May, 387 (6632): 509-12.
  • Chen P; Xie H; Wells A. Mitogenic signaling from the EGF receptor is attenuated by a phospholipase C-g/protein kinase C feedback mechanism. Molecular Biology of the Cell, 1996 Jun, 7 (6): 871-81.
  • Chin YE; Kitagawa M; Su WC; You ZH; Iwamoto Y; Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibidor p21WAF1/CIP1 mediated by STAT1. Science, 1996 May, 272 (5262): 719-22.
  • Chin YE; Kitagawa M; Kuida K; Flavell RA; Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Molecular and Cellular Biology, 1997 Sep, 17 (9): 5328-37.
  • Daly RJ. The Grb7 family of signalling proteins. Cellular Signaling, 1998 Oct, 10 (9): 613-8.
  • Daub H; Weiss FU; Wallasch C; Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature, 1996 Feb, 379 (6565): 557-60.
  • Daub H; Wallasch C; Lankenau A; Herrlich A; Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. European Molecular Biology Organization Journal, 1997 Dec, 16 (23): 7032-44.
  • Davis RJ. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. Journal of Biological Chemistry, 1988 Jul, 263 (19): 9462-9.
  • Davis RJ. The mitogen-activated protein kinase signal transduction pathway. Journal of Biological Chemistry, 1993 Jul, 268 (20): 14553-6.
  • De Frutos T; Martín-Nieto J; Villalobo A. Phosphorylation of calmodulin by permeabilized fibroblasts overexpressing the human epidermal growth factor receptor. Biological Chemistry, 1997 Jan, 378 (1): 31-8.
  • Dekker LV; Parker PJ. Protein kinase C: a question of specificity. Trends in Biochemical Sciences, 1994 Feb, 19 (2): 73-7.
  • Di Fiore PP; Pierce JH; Fleming TP; Hazan R; Ullrich A; King CR; Schlessinger J; Aaronson SA. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell, 1987 Dec, 51 (6): 1063-70.
  • Donato NJ; Gallick GE; Steck PA; Rosenblum MG. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells: correlation with cytotoxicity. Journal of Biological Chemistry, 1989 Dec, 264 (34): 20474-81.
  • Donato NJ; Rosenblum MG; Steck PA. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism. Cell Growth and Differentiation, 1992 May, 3 (5): 259-68.
  • Downward J. Ras signalling and apoptosis. Current Opinion in Genetics and Development, 1998 Feb, 8 (1): 49-54.
  • Downward J; Parker P; Waterfield MD. Autophosphorylation sites on the epidermal growth factor receptor. Nature, 1984 Oct , 311 (5985): 483-5
  • Earp HS; Dawson TL; Li X; Yu H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Research and Treatment, 1995 Jul, 35 (1): 115-32.
  • Ekstrand AJ; Longo N; Hamid ML; Olson JJ; Liu L; Collins VP; James CD. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 1994 Aug, 9 (8): 2313-20.
  • Emlet DR; Moscatello DK; Ludlow LB; Wong AJ. Subsets of epidermal growth factor receptors during activation and endocytosis. Journal of Biological Chemistry, 1997 Feb, 272 (7): 4079-86.
  • Estrada C; Gomez C; Martin-Nieto J; De Frutos T; Jimenez A; Villalobo A. Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochemical Journal, 1997 Sep, 326 (2): 369-76.
  • Ettenberg SA; Keane MM; Nau MM; Frankel M; Wang LM; Pierce JH; Lipkowitz S. cbl-b inhibits epidermal growth factor receptor signaling. Oncogene, 1999 Mar, 18 (10): 1855-66.
  • Feinmesser RL; Wicks SJ; Taverner CJ; Chantry A. Ca2+/calmodulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplamic tail and serine744 within the kinase domain to regulate signal generation. Journal of Biological Chemistry, 1999 Jun, 274 (23): 16168-73.
  • Fenstermaker RA; Ciesielski MJ; Castiglia GJ. Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cells. Oncogene, 1998 Jul, 16 (26): 3435-43.
  • Fiddes RJ; Campbell DH; Janes PW; Sivertsen SP; Sasaki H; Wallasch C; Daly RJ. Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3. Journal of Biological Chemistry, 1998 Mar, 273 (13): 7717-24.
  • Friedman BA; van Amsterdam J; Fujiki H; Rosner MR. Phosphorylation at threonine-654 is not required for negative regulation of the epidermal growth factor receptor by non-phorbol tumor promoters. Proceedings of the National Academy of Sciences of the United States of America, 1989 Feb, 86 (3): 812-6.
  • Galcheva-Gargova Z; Theroux SJ; Davis RJ. The epidermal growth factor receptor is covalently linked to ubiquitin. Oncogene, 1995 Dec, 11 (12): 2649-55.
  • García-Manero G; Moscatello DK; Emlet DR; Wong AJ. Association of the epidermal growth factor receptor with the beta chain of the granulocyte macrophage colony stimulating factor receptor. Blood, 1998, 92 (Suppl 1): A836.
  • Gray A; Dull TJ; Ullrich A. Nucleotide sequence of de epidermal growth factor cDNA predicts a 128,000 molecular weigth protein precursor. Nature, 1983 Jun, 303 (5919): 722-5.
  • Groenen LC; Nice EC; Burgess AW. Structure-function relationships for the EGF/TGF-a family of mitogens. Growth Factors, 1994, 11 (4): 235-57.
  • Guy PM; Platko JV; Cantley LC; Cerione RA; Carraway KL. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proceedings of the National Academy of Sciences of the United States of America, 1994 Aug, 91 (17): 8132-6.
  • Habib AA; Högnason T; Ren J; Stefansson K; Ratan RR. (1998) The epidermal growth factor receptor associates with and recruits phosphatidylinositol 3-kinase to the platelet-derived growth factor b receptor. Journal of Biological Chemistry, 1998 Mar, 273 (12): 6885-91.
  • Haley JD; Hsuan JJ; Waterfield MD. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Oncogene, 1989 Mar, 4 (3): 273-83.
  • Hanks SK; Quinn AM; Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science, 1988 Jul, 241 (4861): 42-52.
  • Hashimoto A; Kurosaki M; Gotoh N; Shibuya M; Kurosaki T. Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. Journal of Biological Chemistry, 1999 Jul, 274 (29): 20139-43.
  • Heldi CH. SH2 domains: elements that control protein interactions during signal transduction. Trends in Biochemical Sciences, 1991 Dec, 16 (12): 450-2.
  • Hernández-Sotomayor SM; Carpenter G. Epidermal growth factor receptor: elements of intracellular communication. Journal of Membrane Biology, 1992 Jun, 128 (2): 81-9.
  • Hernández-Sotomayor SM; Mumby M; Carpenter G. Okadaic acid-induced hyperphosphorylation of the epidermal growth factor receptor. Comparison with receptor phosphorylation and functions affected by another tumor promoter, 12-O-tetradecanoylphorbol-13-acetate. Journal of Biological Chemistry, 1991 Nov, 266 (31): 21281-6
  • Hide G; Gray A; Harrison CM; Tait A. Identification of an epidermal growth factor receptor homologue in trypanosomes. Molecular and Biochemical Parasitology, 1989 Aug, 36 (1): 51-9.
  • Hill RJ; Sternberg PW. The gene lin-3 encodes an inductive signal for vulval development in C. elegans. Nature, 1992 Aug, 358 (6386): 470-6.
  • Holbrook MR; O?Donnell JB; Slakey LL; Gross DJ. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992. Biochemistry, 1999 Jul, 38 (29): 9348-56.
  • Hu P; Margolis B; Skolnik EY; Lammers R; Ullrich A; Schlessinger J. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Molecular and Cellular Biology, 1992 Mar, 12 (3): 981-90.
  • Hughes AR; Bird GS; Obie JF; Thastrup O; Putney JWJr. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells. Molecular Pharmacology, 1991 Aug, 40 (2): 254-62.
  • Hug H; Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochemical Journal, 1993 Apr, 291 (2): 329-43.
  • Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Biochemical and Biophysical Research Communications, 1991 Aug, 178 (3): 1413-20.
  • Hunter T; Ling N; Cooper JA. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the citoplasmic face of the plasma membrane. Nature, 1984 Oct, 311 (4): 480-3.
  • Kalthoff H; Roeder C; Gieseking J; Humburg I; Schmiegel W. Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor a. Proceedings of the National Academy of Sciences of the United States of America, 1993 Oct, 90 (19): 8972-6.
  • Kim H; Muller WJ. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Experimental Cell Research, 1999 Nov, 253 (1): 78-87.
  • Koch CA; Anderson D; Moran MF; Ellis C; Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science, 1991 May, 252 (5006): 668-74.
  • Kuppuswamy D; Dalton M; Pike LJ. Serine 1002 is a site of in vivo and in vitro phosphorylation of the epidermal growth factor receptor. Journal of Biological Chemistry, 1993 Sep, 268 (25): 19134-42.
  • Lane MD; Ronnett G; Slieker LJ; Kohanski RA; Olson TL. Post-translational processing and activation of insulin and EGF proreceptors. Biochimie, 1985 Oct-Nov, 67 (10-11): 1069-80.
  • Lax I; Burgess WH; Bellot F; Ullrich A; Schlessinger J; Givol D. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling. Molecular and Cellular Biology, 1988 Apr, 8 (4): 1831-4.
  • Lax I; Bellot F; Howk R; Ullrich A; Givol D; Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. European Molecular Biology Organization Journal, 1989 Feb, 8 (2): 421-7.
  • Levkowitz G; Waterman H; Zamir E; Kam S; Oved S; Langdon WY; Beguinot L; Geiger B; Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes and Development, 1998 Dec, 12 (23): 3663-74.
  • Li N; Schlessinger J; Margolis B. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene, 1994 Dec, 9 (12): 3457-65.
  • Liu XQ; Pawson T. The epidermal growth factor receptor phosphorylates GTPase-activating protein (GAP) at Tyr-460, adjacent to the GAP SH2 domains. Molecular and Cellular Biology, 1991 May, 11 (5): 2511-6.
  • Logan SK; Falasca M; Hu P; Schlessinger J. Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway. Molecular and Cellular Biology, 1997 Oct, 17 (10): 5784-90.
  • Lowenstein EJ; Daly RJ; Batzer AG; Li W; Margolis B; Lammers R; Ullrich A; Skolnik EY; Bar-Sagi D; Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell, 1992 Aug, 70 (3): 431-42.
  • Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation. Journal of Biological Chemistry, 1990 Nov, 265 (33): 20517-23.
  • Luttrell LM; Della Rocca GJ; van Biesen T; Luttrell DK; Lefkowitz RJ. Gbg subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor: a scaffold for G-protein-coupled receptor-mediated Ras activation. Journal of Biological Chemistry, 1997 Feb, 272 (7): 4637-44.
  • Margolis; B. Proteins with SH2 domains: transducers in the tyrosine kinase signaling pathway. Cell Growth and Differentiation, 1992 Jan, 3 (1): 73-80.
  • Margolis B; Rhee SG; Felder S; Mervic M; Lyall R; Levitzki A; Ullrich A; Zilberstein A; Schlessinger J. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell, 1989 Jun, 57 (7): 1101-7.
  • Margolis B; Silvennoinen O; Comoglio F; Roonprapunt C; Skolnik E; Ullrich A; Schlessinger J. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proceedings of the National Academy of Sciences of the United States of America, 1992 Oct, 89 (19): 8894-8.
  • Martín-Nieto J; Villalobo A. The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site. Biochemistry, 1998 Jan, 37 (1): 227-36.
  • Massagué J. Transforming growth factor-a. A model for membrane-anchored growth factors. Journal of Biological Chemistry, 1990 Dec, 265 (35): 21393-6.
  • Massagué J; Pandiella A. Membrane-anchored growth factors. Annual Review of Biochemistry, 1993, 62: 515-41.
  • Mellman I. Endocytosis and molecular sorting. Annual Review of Cell and Developmental Biology, 1996, 12: 575-625.
  • Merlino GT; Xu YH; Ishii S; Clark AJ; Semba K; Toyoshima K; Yamamoto T; Pastan I. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science, 1984 Apr, 224 (4647): 417-9.
  • Mikoshiba K. Inositol 1,4,5-trisphosphate receptor. Trends in Pharmacological Sciences, 1993 Mar, 14 (3): 86-9.
  • Minden A; Lin A; Claret FX; Abo A; Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 1995 Jun, 81 (7): 1147-57.
  • Morrison P; Takishima K; Rosner MR. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase. Journal of Biological Chemistry, 1993 Jun, 268 (21): 15536-43.
  • Morrison P; Saltiel AR; Rosner MR. Role of mitogen-activated protein kinase in regulation of the epidermal growth factor receptor by protein kinase C. Journal of Biological Chemistry, 1996 May, 271 (22): 12891-6.
  • Muskavitch MA; Hoffmann FM. Homologs of vertebrate growth factors in Drosophila melanogaster and other invertebrates. Current Topics in Developmental Biology, 1990, 24: 289-328.
  • Nishibe S; Wahl MI; Hernández-Sotomayor SM; Tonks NK; Rhee SG; Carpenter G. Increase of the catalytic activity of phospholipase Cg1 by tyrosine phosphorylation. Science, 1990 Nov, 250 (4985): 1253-6.
  • Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America, 1994 Aug, 91 (16): 7727-31.
  • Northwood IC; González FA; Wartmann M; Raden DL; Davis RJ. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. Journal of Biological Chemistry, 1991 Aug, 266 (23):15266-76.
  • Palomo-Jiménez PI; Hernández-Hernando S; García-Nieto RM; Villalobo A. A method for the purification or phospho(Tyr)calmodulin free of nonphosphorylated calmodulin. Protein Expression and Purification, 1999 Aug, 16 (3): 388-95.
  • Peles E; Yarden Y. Neu and its ligands: from an oncogene to neural factors. Bioessays, 1993 Dec, 15 (12): 815-24.
  • Pelicci G; Lanfrancone L; Grignani F; McGlade J; Cavallo F; Forni G; Nicoletti I; Grignani F; Pawson T; Pelicci PG. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell, 1992 Jul, 70 (1): 93-104.
  • Pelley RJ; Maihle NJ; Boerkoel C; Shu HK; Carter TH; Moscovici C; Kung HJ. Disease tropism of c-erbB: effects of carboxyl-terminal tyrosine and internal mutations on tissue-specific transformation. Proceedings of the National Academy of Sciences of the United States of America, 1989 Sep, 86 (18): 7164-8.
  • Peppelenbosch MP; Tertoolen LG; der Hertog J; de Laat SW. Epidermal growth factor activates calcium channels by phospholipaseA2/5-lipoxygenase-mediated leukotriene C4 production. Cell, 1992 Apr, 69 (2): 295-303.
  • Pinkas-Kramarski R; Shelly M; Glathe S; Ratzkin BJ; Yarden Y. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. Journal of Biological Chemistry, 1996 Aug, 271 (32): 19029-32.
  • Qiu Y; Ravi L; Kung H-J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature, 1998 May, 393 (6680): 83-5.
  • Rall LB; Scott J; Bell GI; Crawford RJ; Penschow JD; Niall HD; Coghlan JP. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature, 1985 Jan, 313 (5999): 228-31.
  • Rhee SG; Choi KD. Regulation of inositol phospholipid-specific phospholipase C isozymes. Journal of Biological Chemistry, 1992 Jun, 267 (18): 12393-6.
  • Riese DJ; Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays, 1998 Jan, 20 (1): 41-8.
  • Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature, 1993 May, 363 (6424): 83-5.
  • Ruff-Jamison S; McGlade J; Pawson T; Chen K; Cohen S. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. Journal of Biological Chemistry, 1993 Apr, 268 (11): 7610-2.
  • Russo MW; Lukas TJ; Cohen S; Staros JV. Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase. Journal of Biological Chemistry, 1985 May, 260 (9): 5205-8.
  • Sabbatini P; McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. Journal of Biological Chemistry, 1999 Aug, 274 (34): 24263-9.
  • San José E; Benguría A; Geller P; Villalobo A. Calmodulin inhibits the epidermal growth factor receptor tyrosine kinase. Journal of Biological Chemistry, 1992 Jul, 267 (21): 15237-45.
  • Sato K; Sato A; Aoto M; Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochemical and Biophysical Research Communications, 1995 Oct, 215 (3): 1078-87.
  • Schalkwijk CG; Spaargaren M; Defize LH; Verkleij AJ; van den Bosch H; Boonstra J. Epidermal growth factor (EGF) induces serine phosphorylation-dependent activation and calcium-dependent translocation of the cytosolic phospholipase A2. European Journal of Biochemistry, 1995 Aug, 231 (3): 593-601.
  • Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends in Biochemical Sciences, 1988 Nov, 13 (11): 443-7.
  • Serth J; Weber W; Frech M; Wittinghofer A; Pingoud A. Binding of the H-ras p21 GTPase activating protein by the activated epidermal growth factor leads to inhibition of the p21GTPase activity in vitro. Biochemistry, 1992 Jul, 31 (28): 6361-5.
  • Slieker LJ; Lane MD. Post-translational processing of the epidermal growth factor receptor. Glycosylation-dependent acquisition of ligand-binding capacity. Journal of Biological Chemistry, 1985 Jan, 260 (2): 687-90.
  • Soderquist AM; Carpenter G. Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. Journal of Biological Chemistry, 1984 Oct, 259 (20): 12586-94.
  • Soltoff SP. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor: phorbol ester or [Ca2+]i elevation can substitute for receptor activation. Journal of Biological Chemistry, 1998 Sep, 273 (36): 23110-7.
  • Soltoff SP; Carraway KL; Prigent SA; Gullick WG; Cantley LC. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Molecular and Cellular Biology, 1994 Jun, 14 (69): 3550-8.
  • Sorkina T; Bild A; Tebar F; Sorkin A. Clathrin, adaptors and eps15 in endosomes containing epidermal growth factor receptors. Journal of Cell Science, 1999 Feb, 112 (3): 317-27.
  • Stein D; Wu J; Fuqua SA; Roonprapunt C; Yajnik V; D'Eustachio P; Moskow JJ; Buchberg AM; Osborne CK; Margolis B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. European Molecular Biology Organization Journal, 1994 Mar, 13 (6): 1331-40.
  • Sternberg PW; Lesa G; Lee J; Katz WS; Yoon C; Clandini TR; Huang LS; Chamberlin HM; Jongeward G. LET-23-mediated signal transduction during Caenorhabditis elegans development. Molecular Reproduction and Development, 1995 Dec, 42 (4): 523-8.
  • Stover DR; Becker M; Liebetanz J; Lydon NB. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85a. Journal of Biological Chemistry, 1995 Jun, 270 (26): 15591-7.
  • Sun H; Chen Z; Poppleton H; Scholich K; Mullenix J; Weipz GJ; Fulgham DL; Bertics PJ; Patel TB. The juxtamembrane, cytosolic region of the epidermal growth factor receptor is involved in association with a-subunit of Gs. Journal of Biological Chemistry, 1997 Feb, 272 (9): 5413-20.
  • Takishima K; Griswold-Prenner I; Ingebritsen T; Rosner MR. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proceedings of the National Academy of Sciences of the United States of America, 1991 Mar, 88 (6): 2520-4.
  • Taylor JM; Mitchell WM; Cohen S. Epidermal growth factor. Physical and chemical properties. Journal of Biological Chemistry, 1972 Sep, 247 (18): 5928-34.
  • Theroux SJ; Taglienti-Sian C; Nair N; Countaway JL; Robinson HL; Davis RJ. Increased oncogenic potential of ErbB is associated with the loss of a COOH-terminal domain serine phosphorylation site. Journal of Biological Chemistry, 1992 Apr, 267 (12): 7967-70.
  • Tice DA; Biscardi JS; Nickles AL; Parsons SJ. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proceedings of the National Academy of Sciences of the United States of America, 1999 Feb, 96 (4):1415-20.
  • Tiganis T; Kemp BE; Tonks NK. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. Journal of Biological Chemistry, 1999 Sep, 274 (39): 27768-75.
  • Todderud G; Carpenter G. Presence of mannose phosphate on the epidermal growth factor receptor in A-431 cells. Journal of Biological Chemistry, 1988 Dec, 263 (34): 17893-6.
  • Toker A. The synthesis and cellular roles of phosphatidylinositol 4,5-bisphosphate. Current Opinion in Cell Biology, 1998 Apr, 10 (2): 254-61.
  • Torrisi MR; Lotti LV; Belleudi F; Gradini R; Saldini AE; Confalonieri S; Pelicci PG; Di Fiore PP. Eps15 is recruited to the plasma membrane upon epidermal prowth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Molecular Biology of the Cell, 1999 Feb, 10 (2): 417-34.
  • Toyoda H; Komurasaki T; Uchida D; Takayama Y; Isobe T; Okuyama T; Hanada K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. Journal of Biological Chemistry, 1995 Mar, 270 (13): 7495-500.
  • Trowbridge IS; Collawn JF; Hopkins CR. Signal-dependent membrane protein trafficking in the endocytic pathway. Annual Review of Cellular Biology, 1993, 9: 129-61.
  • Tsai W; Morielli AD; Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. European Molecular Biology Organization Journal, 1997 Aug, 16 (15): 4597-605.
  • Tsui L-C, Farrall M. Report of the committee on the genetic constitution of chromosome 7. In: Human Gene Mapping 11. Cytogenetics and Cell Genetics, 1991, 58: 337-81.
  • Ullrich A; Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell, 1990 Apr, 61 (2): 203-12.
  • Ullrich A; Coussens L; Hayflick JS; Dull TJ; Gray A; Tam AW; Lee J; Yarden Y; Libermann TA; Schlessinger J; Downward J; Mayes ELV; Whittle N; Waterfield MD; Seeburg PH. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 1984 May-Jun, 309 (5967): 418-25.
  • Van der Geer P; Pawson T. The PTB domain: a new protein module implicated in signal transduction. Trends in Biochemical Sciences, 1995 Jul, 20 (7): 277-80.
  • Vanhaesebroeck B; Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Experimental Cell Research, 1999 Nov, 253 (1): 239-54.
  • Vega QC; Cochet C; Filhol O; Chang CP; Rhee SG; Gill GN. A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C. Molecular and Cellular Biology, 1992 Jan, 12 (1): 128-35.
  • Villalobo A; Ruano MJ; Palomo-Jiménez PI; Li H; Martín-Nieto J. The epidermal growth factor receptor and the calcium signal. In: Calcium: Molecular Basis of Calcium Action in Biology and Medicine (Pochet R, Donato R, Haiech J, Heizmann C, Gerke V Eds.), Kluwer Academic Publishers, Boston MA, 2000 (in press).
  • Vojtek AB; Der CJ. Increasing complexity of the Ras signaling pathway. Journal of Biological Chemistry, 1998 Aug, 273 (32): 19925-8.
  • Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but no proliferation. Molecular and Cellular Biology, 1998 Dec, 18 (12): 7192-204.
  • Walton GM; Chen WS; Rosenfeld MG; Gill GN. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. Journal of Biological Chemistry, 1990 Jan, 265 (3): 1750-4.
  • Waterman H; Sabanai I; Geiger B; Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. Journal of Biological Chemistry, 1998 May, 273 (22): 13819-27.
  • Waterman H; Levkowitz G; Alroy I; Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. Journal of Biological Chemistry, 1999 Aug, 274 (32): 22151-4.
  • Weiss A; Schlessinger J. Switching signals on or off by receptor dimerization. Cell, 1998 Aug, 94 (3): 277-80.
  • Wells A. EGF receptor. International Journal of Biochemistry and Cell Biology, 1999 Jun, 31 (6): 637-43.
  • Wong AJ; Ruppert JM; Bigner SH; Grzeschik CH; Humphrey PA; Bigner DS; Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences of the United States of America, 1992 Apr, 89 (7): 2965-9.
  • Wood KW; Sarnecki C; Roberts TM; Blenis J. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell, 1992 Mar, 68 (6): 1041-50.
  • Yamamoto T; Hihara H; Nishida T; Kawai S; Toyoshima K. A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell, 1983 Aug, 34 (1): 225-32.
  • Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature, 1997 Nov, 390 (6655): 91-6.
  • Yarden Y; Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry, 1987 Mar, 26 (5): 1434-42.
  • Introducción
    La familia de receptores ErbB y sus ligandos
    Rutas de señalización mediadas por el EGFR
    Regulación del EGFR
    Transactivación de receptores ErbB por otras familias de receptores
    Internalización de EGFR
    Implicación de receptores ErbB en carcinogénesis
    Bibliografía

    NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





    Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
    Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
    caibco@ucv.ve
    Este portal ha sido desarrollado gracias al apoyo del Fonacit